P3 Health Partners Inc. (PIIIW)
USD 0.01
(0.0%)
USD 0.01
(0.0%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 108.31 Million USD | 2.25% |
| 2022 | 105.93 Million USD | 22.76% |
| 2021 | 86.29 Million USD | 76.04% |
| 2020 | 49.02 Million USD | 152.61% |
| 2019 | 19.4 Million USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 133.12 Million USD | 12.7% |
| 2024 Q1 | 118.12 Million USD | 9.05% |
| 2023 Q2 | 119.98 Million USD | -0.8% |
| 2023 FY | 108.31 Million USD | 2.25% |
| 2023 Q4 | 108.31 Million USD | -11.07% |
| 2023 Q3 | 121.8 Million USD | 1.52% |
| 2023 Q1 | 120.94 Million USD | 14.17% |
| 2022 Q1 | 86.32 Million USD | 0.04% |
| 2022 Q4 | 105.93 Million USD | 16.21% |
| 2022 FY | 105.93 Million USD | 22.76% |
| 2022 Q3 | 91.15 Million USD | 0.64% |
| 2022 Q2 | 90.57 Million USD | 4.92% |
| 2021 FY | 86.29 Million USD | 76.04% |
| 2021 Q4 | 86.29 Million USD | 31.08% |
| 2021 Q3 | 65.83 Million USD | 5.46% |
| 2021 Q1 | 64.82 Million USD | 32.23% |
| 2021 Q2 | 62.42 Million USD | -3.7% |
| 2020 Q4 | 49.02 Million USD | 0.0% |
| 2020 Q1 | - USD | 0.0% |
| 2020 FY | 49.02 Million USD | 152.61% |
| 2019 FY | 19.4 Million USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 1.34 Billion USD | 91.932% |
| Addus HomeCare Corporation | 124.13 Million USD | 12.739% |
| AirSculpt Technologies, Inc. | 69.5 Million USD | -55.848% |
| Amedisys, Inc. | 346.76 Million USD | 68.763% |
| American Oncology Network, Inc. | 120.44 Million USD | 10.067% |
| Astrana Health, Inc. | 296.26 Million USD | 63.438% |
| Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 91.513% |
| IMAC Holdings, Inc. | - USD | -Infinity% |
| biote Corp. | 106.63 Million USD | -1.584% |
| Cryo-Cell International, Inc. | 9.28 Million USD | -1066.982% |
| Cross Country Healthcare, Inc. | 2.66 Million USD | -3967.555% |
| COMPASS Pathways plc | 28.75 Million USD | -276.67% |
| DocGo Inc. | 15.16 Million USD | -614.415% |
| The Ensign Group, Inc. | 1.78 Billion USD | 93.931% |
| Healthcare Services Group, Inc. | 11.23 Million USD | -864.121% |
| InnovAge Holding Corp. | 100.49 Million USD | -7.784% |
| Assure Holdings Corp. | 505 Thousand USD | -21349.307% |
| The Joint Corp. | 2 Million USD | -5315.95% |
| LifeStance Health Group, Inc. | 280.28 Million USD | 61.354% |
| Mobile-health Network Solutions Class A Ordinary Shares | 381.43 Thousand USD | -28297.463% |
| ModivCare Inc. | 983.75 Million USD | 88.989% |
| NewGenIvf Group Limited | 118.97 Thousand USD | -90940.436% |
| Novo Integrated Sciences, Inc. | 1.75 Million USD | -6059.336% |
| Option Care Health, Inc. | 1.05 Billion USD | 89.749% |
| P3 Health Partners Inc. | 108.31 Million USD | 0.0% |
| The Pennant Group, Inc. | 312.51 Million USD | 65.339% |
| Surgery Partners, Inc. | 2.03 Billion USD | 94.674% |
| Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| Talkspace, Inc. | - USD | -Infinity% |
| The Oncology Institute, Inc. | 86.82 Million USD | -24.754% |
| The Oncology Institute, Inc. | 86.82 Million USD | -24.754% |